A Case of a Neuroendocrine Tumor in a Liver Transplant Patient: Diagnostic and Management Difficulties
Open Access
Abstract
Neuroendocrine tumors (NETs) of the liver are a rare entity. NETs are often poorly recognized, with diagnostic difficulties and differential challenges between primary tumors of the liver and metastases from other organs, mainly from the gastrointestinal tract. Multidisciplinary and multi-technical diagnosis is mandatory to properly treat these tumors. This case describes the complex history and the treatment course of a 68-year-old man with a history of NET onset after liver transplantation. Liver transplantation is the treatment of choice for patients with advanced liver disease or acute liver failure, but careful pre- and post-transplant patient monitoring is required. Liver transplant patients receive immunosuppressive therapy, and donor livers should be screened to exclude potential malignancies. This clinical case, in addition to emphasizing the diagnostic and therapeutic difficulty of hepatic NET, underlines the role of post-transplant immunosuppressive therapy and pre-transplant screening, which includes a thorough evaluation of donor and recipient history, physical examination, and laboratory tests. Moreover, post-transplant immunosuppressive therapy is essential to maintain the viability of the transplanted organ, but it is not free from potential risks, including an increased risk of cancer. Therefore, close monitoring of therapy is necessary to optimize long-term results and the patient’s quality of life.Keywords
This publication has 22 references indexed in Scilit:
- Diagnostic problem of Primary Hepatic Neuroendocrine Tumor in 18-year-old womanInternational Journal of Surgery Case Reports, 2022
- Primary hepatic neuroendocrine tumour with multiple liver metastasesInternational Journal of Surgery Case Reports, 2021
- Neuroendocrine Tumors—Less Well Known, Often Misunderstood, and Rapidly Growing in IncidenceJAMA Oncology, 2020
- 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumorsExpert Review of Gastroenterology & Hepatology, 2019
- Primary hepatic neuroendocrine tumours—Case series of a rare malignancyInternational Journal of Surgery Case Reports, 2019
- Increased incidence trend of low-grade and high-grade neuroendocrine neoplasmsEndocrine, 2017
- Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysisAnnals of Oncology, 2015
- Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinomaJournal of Hepatology, 2013
- Spectrum of Cancer Risk Among US Solid Organ Transplant RecipientsJAMA, 2011
- Staging cholangiocarcinoma by imaging studiesHPB, 2008